Crossmark

A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database

Crossref DOI link: https://doi.org/10.1186/s12885-020-07019-5

Published Online: 2020-06-08

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Chengzhuo

Yang, Jin

Xu, Fengshuo

Han, Didi

Zheng, Shuai

Kaaya, Rahel Elishilia

Wang, Shengpeng

Lyu, Jun http://orcid.org/0000-0002-2237-8771
Funding

Funding for this research was provided by:

The National Social Science Foundation of China (16BGL183)
License Information

Text and Data Mining valid from 2020-06-08

Version of Record valid from 2020-06-08
More Information

Article History

Received: 17 December 2019

Accepted: 28 May 2020

First Online: 8 June 2020

Ethics approval and consent to participate

: Since cancer is a reportable disease in every state in the USA, informed patient consent is not required. When data usege agreement was signed, data on cancer research become available to the public.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below